Calidi Biotherapeutics Inc [CLDI] moved up 60.19: Why It’s Important

TTWO

Calidi Biotherapeutics Inc [AMEX: CLDI] surged by $1.27 during the normal trading session on while it closed the day at $3.38.

Calidi Biotherapeutics Inc stock has also gained 133.10% of its value over the past 7 days. However, CLDI stock has inclined by 115.29% in the 3 months of the year. Over the past six months meanwhile, it has gained 44.69% and lost -77.62% year-on date.

The market cap for CLDI stock reached $39.47 million, with 11.68 million shares outstanding and 9.73 million shares in the current float. Compared to the average trading volume of 555.07K shares, CLDI reached a trading volume of 23256299 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about Calidi Biotherapeutics Inc [CLDI]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CLDI shares is $6.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CLDI stock is a recommendation set at 1.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

H.C. Wainwright have made an estimate for Calidi Biotherapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 22, 2023. While these analysts kept the previous recommendation, Robert W. Baird raised their target price to Outperform. The new note on the price target was released on October 09, 2023, representing the official price target for Calidi Biotherapeutics Inc stock.

CLDI stock trade performance evaluation

Calidi Biotherapeutics Inc [CLDI] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 133.10. With this latest performance, CLDI shares gained by 221.90% in over the last four-week period, additionally plugging by 44.69% over the last 6 months – not to mention a drop of -84.28% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CLDI stock in for the last two-week period is set at 90.09, with the RSI for the last a single of trading hit 94.35, and the three-weeks RSI is set at 85.45 for Calidi Biotherapeutics Inc [CLDI]. The present Moving Average for the last 50 days of trading for this stock 1.23, while it was recorded at 2.08 for the last single week of trading, and 2.89 for the last 200 days.

Calidi Biotherapeutics Inc [CLDI]: An insightful look at the core fundamentals

Calidi Biotherapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.12 and a Current Ratio set at 0.12.

Calidi Biotherapeutics Inc [CLDI]: Institutional Ownership

There are presently around $2.71%, or 3.31%% of CLDI stock, in the hands of institutional investors.